A retrospective clinical analysis of pharmacological modalities used for symptomatic relief of Raynaud's phenomenon in children treated in a UK paediatric rheumatology centre.
Kapil
K
Gargh
Eileen M
EM
Baildam
Gavin A
GA
Cleary
Michael W
MW
Beresford
Liza J
LJ
McCann
D000279:Administration, Cutaneous; D000293:Adolescent; D002121:Calcium Channel Blockers / Q000008:administration & dosage; D002648:Child; D002675:Child, Preschool; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D005996:Nitroglycerin / Q000008:administration & dosage; D011928:Raynaud Disease / Q000188:drug therapy*; D012189:Retrospective Studies; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000008:administration & dosage
D002121:Calcium Channel Blockers; D003692:Delayed-Action Preparations; D014665:Vasodilator Agents; D005996:Nitroglycerin